SAM
RLAY icon

Shell Asset Management’s Relay Therapeutics RLAY Stock Holding History

Shell Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$11K Sell
2,151
-4,743
-69% -$18.1K ﹤0.01% 1111
2025
Q2 		$24K Hold
6,894
– – ﹤0.01% 1217
2025
Q1 		$18K Sell
6,894
-266
-4% -$1.04K ﹤0.01% 1234
2024
Q4 		$29K Hold
7,160
– – ﹤0.01% 1225
2024
Q3 		$51K Buy
+7,160
New +$53.5K ﹤0.01% 1174
2024
Q1 		$46K Sell
7,010
-474
-6% -$4.62K ﹤0.01% 1171
2023
Q4 		$82K Buy
+7,484
New +$63.2K ﹤0.01% 1106

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Shell Asset Management's RLAY Position: Q3 2025 in Review

Shell Asset Management reduced its Relay Therapeutics (RLAY) stake by 69% in Q3 2025, selling an estimated $18.1K and leaving 2,151 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1111.

Shell Asset Management first reported a position in RLAY in Q4 2023 and has held it in 7 quarters since. The position peaked at $82K in Q4 2023. 199 funds tracked by Wall St. Rank hold RLAY as of Q3 2025.

  • Shell Asset Management held 2,151 shares of Relay Therapeutics worth $11K as of Q3 2025.
  • Shell Asset Management sold 4,743 Relay Therapeutics shares in Q3 2025, an estimated $18.1K.
  • Relay Therapeutics made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #1111 holding.
  • Shell Asset Management first reported a position in Relay Therapeutics in Q4 2023 and has held it in 7 quarters since.
  • Shell Asset Management's Relay Therapeutics position peaked at $82K in Q4 2023.
  • 199 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.